Document:

Share Purchase Agreement

 Exhibit 10.1 
  
 Dated 6 July 2005 
  
 The legal entities and the individuals set out in Part 1 of Schedule 1 
  
 and 
  
 Millipore International Holding Company B.V. 
  
 SHARE PURCHASE AGREEMENT 
  
 relating to the sale and purchase of shares in 
  
 NovAseptic AB (publ) 
  
 

 
  
 Linklaters Advokatbyrå 
 Regeringsgatan 67 
 Box 7833 
 SE-103 98 Stockholm 
  
 Telephone (46-8) 665 66 00 
 Facsimile (46-8) 667 68 83 

					
	1	  	Definitions	  	1
			
	2	  	Sale and Purchase of the Shares	  	3
			
	3	  	Purchase Price	  	3
			
	4	  	Conditions	  	5
			
	5	  	Pre-Closing	  	6
			
	6	  	Closing	  	7
			
	7	  	Post-Closing Obligations	  	7
			
	8	  	Warranties	  	8
			
	9	  	Sellers’ Liability and Purchaser’s Remedies under this Agreement	  	14
			
	10	  	Limitation of Liability	  	15
			
	11	  	Third Party Claims	  	17
			
	12	  	Confidentiality	  	18
			
	13	  	Other Provisions	  	18

  

 i 

 This Share Purchase Agreement (the “Agreement”) is made on 6 July 2005 between:

  

	(1)	The legal entities and the individuals set out in Part 1 of Schedule 1 (the “Sellers”); and 

  

	(2)	Millipore International Holding Company B.V., Paasheuvelweg 3, 1105 CE Amsterdam-Zuidoost, the Netherlands, (the “Purchaser”). 

  
 Background 
  

	(A)	NovAseptic AB (publ) is a public limited liability company incorporated under the laws of Sweden, corporate registration no. 556460-0830, (the “Company”). The
Company develops, markets, sells and maintains key components to the pharmaceutical and biotechnological industries. 

  

	(B)	At the date of this Agreement, the Sellers own approximately 90.12 per cent. of the shares in the Company on a fully diluted basis (the “Shares”) as set out in Part
1 of Schedule 1. For the purpose of this Agreement the remaining shareholders in the Company are referred to as the “Minority Shareholders”. The Minority Shareholders own, in aggregate, approximately 9.88 per cent. of the shares in
the Company on a fully diluted basis (the “Minority Shares”). Following Closing (as defined below), the Purchaser will be able to acquire the Minority Shares by way of compulsory acquisition in accordance with the Swedish Companies
Act (1975:1385). 

  

	(C)	The Sellers have agreed to sell the Shares and the Purchaser has agreed to purchase the Shares on and subject to the terms of this Agreement. 

  

	1	Definitions 

  

	    	The following terms, used in this Agreement, have the following meanings: 

  

	    	“Audited Accounts” means the audited accounts of the Company and the audited consolidated group accounts of the Company for the financial period ended on the
Balance Sheet Date; 

  

	    	“Balance Sheet Date” means 30 April 2005; 

  

	    	“Business Day” means a day on which banks are open for business in Stockholm (excluding Saturdays, Sundays and public holidays); 

  

	    	“Business IP” means all Intellectual Property which is owned or licensed by a Group Company; 

  

	    	“Closing” means the completion of the sale and purchase of the Shares pursuant to Clause 6; 

  

	    	“Closing Balance Sheet” has the meaning given to it in Clause 3.1.2; 

  

	    	“Closing Date” means the date on which Closing takes place; 

  

	    	“Confidential Information” means any information, including, without limitation, financial information, trade secrets, client lists and other proprietary business
information, regarding the Group Companies or any of the Sellers or their affiliated companies; 

  

	    	“Data Room” means the data room containing documents and information relating to the Group made available by the Sellers at Linklaters Advokatbyrå AB,
Regeringsgatan 67; 

  

 1 

 “Disclosure Schedule” means the document enclosed hereto as Schedule 2;

  
 “Draft Minority Sellers’
Agreement” means the document set out in Schedule 3; 
  
 “Encumbrance” means any claim, charge, pledge, mortgage, lien, option, equity, retention of title, right of pre-emption, right of first refusal or third party rights or security interest of any kind;

  
 “Group” or “Group
Companies” means the Company and the Subsidiaries and “Group Company” means any of them; 
  
 “Intellectual Property” means trade marks, trade names, domain names, logos, patents, inventions, registered and unregistered design
rights, copyrights, database rights and all other intellectual or industrial proprietary rights; 
  
 “Key Employees” means the individuals set out in Schedule 4; 
  
 “Management Sellers” means Sten Johansson, Håkan Samuelsson, Nils Årthun, Bruno François
and Johan Westman and “Management Seller” means any of them; 
  
 “Net Working Capital” means all current assets (total assets less total fixed assets less cash and cash equivalents), including but not limited to accounts receivable, inventories, and prepaid
expenses, on a consolidated basis, less current non-interest bearing liabilities, including but not limited to accounts payable, accrued expenses and tax payable, on a consolidated basis; 
  
 “Pension Schemes” has the meaning given to it in Clause
8.10.4; 
  
 “Properties” means the freehold
(Sw. fastighet) and leasehold (Sw. tomträtt) properties, leased by any Group Company and “Property” means any of them; 
  
 “Purchase Price” has the meaning given to it in Clause 3.1; 
  
 “Purchaser’s Group” means any entity directly or indirectly controlling or controlled by or under
common control with the Purchaser, by means of a majority of shares or otherwise; 
  
 “Reference Cash” means SEK 23,647,000 (which corresponds to cash and cash equivalents in the Audited Accounts); 
  
 “Reference Net Working Capital” means SEK 40,848,000 (which corresponds to the Net Working Capital in the
Audited Accounts); 
  
 “Relevant Competition
Authorities” means the competition authorities listed in Schedule 5; 
  
 “Relief” means any relief, loss or losses carried forward, allowance, exemption, set-off, deduction or credit in computing or against profits or Tax; 
  
 “Restricted Activity” means any business which is now
carried on by the Group Companies; 
  
 “Restricted
Employee” means any Key Employee; 
  
 “SCC
Institute” has the meaning given to it in Clause 13.8.1; 
  
 “Sellers’ Warranties” means the warranties given by the Sellers pursuant to Clauses 8.3- 8.16 and “Sellers’ Warranty” means any one of them; 
  

 2 

 “Subsidiaries” means the subsidiaries, details of which are set out in Part 2 of
Schedule 1 and “Subsidiary” means any one of them; 
  
 “Surviving Clauses” means Clauses 1, 12 and 13; 
  
 “Tax” or “Taxes” means income taxes, whether determined by reference to income, profits, gains, and all other taxes,
including but not limited to, transfer taxes, value added taxes, selective purchase taxes, social security fees, administrative fees, duties, charges and withholding taxes, and all penalties, charges, costs and interest relating thereto; 

 
 “Tax Authority” means any taxing or other authority
competent to impose any liability in respect of taxation or responsible for the administration and/or collection of taxation or enforcement of any law in relation to Taxes; and 
  
 “Warranties” means the warranties set out in Clause 8 and “Warranty” means any one of
them. 
  

	2	Sale and Purchase of the Shares 

  

	2.1	On and subject to the terms of this Agreement, the Sellers agree to sell and the Purchaser agrees to purchase the Shares. 

  

	2.2	The Shares shall be sold together with all rights attaching to them as at Closing.  

  

	3	Purchase Price 

  

	3.1	Amount, etc. 

  

	 	3.1.1	The purchase price for the purchase of the Shares under this Agreement shall be SEK 648,830,000 (the “Purchase Price”) (which corresponds to SEK 104.65 per
share), and any adjustment pursuant to Clause 3.1.4 (the “Adjustment Price”). The Purchase Price and the Adjustment Price shall be paid in accordance with Clause 3.2. 

  

	 	3.1.2	As soon as reasonably practicable, but not later than 30 calendar days after the Closing Date, the Purchaser shall deliver to the Sellers a consolidated balance sheet for the
Group as per the Closing Date (the “Closing Balance Sheet”). The Closing Balance Sheet shall be prepared according to Swedish GAAP and the accounting policies, procedures and practises adopted in the Audited Accounts, applied on a
consistent basis. In case the Sellers do not, within 30 calendar days after receipt of the Closing Balance Sheet, deliver a written statement setting forth in detail the items and or amounts on which the Sellers disagree with the Purchaser on the
Closing Balance Sheet, the Sellers shall be deemed to have accepted the Closing Balance Sheet. The Sellers shall be given reasonable access to the books and personnel of the Company in order to verify the merits of the Closing Balance Sheet.

  

	 	3.1.3	In the event that the Sellers object to the Closing Balance Sheet and the Purchaser does not agree with the Sellers’ objections, and such disagreement is not solved
within 30 calendar days after the Purchaser’s receipt of the written statement from the Sellers, the matter shall upon written request by either party be referred to arbitration with an accounting arbitrator (which, for the purposes of this
Agreement shall refer to an international accounting firm to be appointed by the parties) acting 

  

 3 

	 	 
as sole arbitrator. Such accounting arbitrator shall present its decision to the parties in written form within 60 calendar days from its appointment. The
decision of the accounting arbitrator shall be final and binding upon the parties and the parties shall equally share the costs for such arbitration. 

  

	 	3.1.4	If the cash and cash equivalents (such cash and cash equivalents to be reduced by any increase in cash resulting from subscription pursuant to the option rights referred to
in Schedule 7) plus Net Working Capital set out in the Closing Balance Sheet, as established in accordance with Clause 3.1.2 or 3.1.3 above, whichever may be the case, is greater than the Reference Cash plus the Reference Net Working Capital set out
in the balance sheet of the Audited Accounts, such exceeding amount shall be paid by the Purchaser to the Sellers in accordance with Clause 3.2 below. If the cash and cash equivalents (such cash and cash equivalents to be reduced by any increase in
cash resulting from subscription pursuant to the option rights referred to in Schedule 7) plus Net Working Capital set out in the Closing Balance Sheet, as established in accordance with Clause 3.1.2 or 3.1.3 above, whichever may be the case, is
less than the Reference Cash plus the Reference Net Working Capital set out in the balance sheet of the Audited Accounts, such deficit shall be paid by the Sellers to the Purchaser in accordance with Clause 3.2 below. 

  

	3.2	Method of Payment 

  

	 	3.2.1	All cash payments by the Purchaser to the Sellers under this Agreement shall be made to such bank account as the Sellers shall designate in writing not later than three
Business Days prior to the Closing Date. 

  

	 	3.2.2	All cash payments by the Sellers to the Purchaser under this Agreement shall be made to such bank account as the Purchaser shall designate in writing not later than three
Business Days prior to the Closing Date. 

  

	 	3.2.3	The Purchase Price shall be paid by the Purchaser at Closing pursuant to Clause 6.3 below. 

  

	 	3.2.4	Any Adjustment Price to be paid by the Purchaser or the Sellers, whichever may be the case, pursuant to Clause 3.1.4 above shall be made within ten Business Days after
establishment of the Closing Balance Sheet. 

  

	3.3	Reduction of Purchase Price  

  
 Any payment made by the Sellers to the Purchaser in respect of any claim for breach of this Agreement shall be made by way of adjustment of the Purchase
Price and the Purchase Price shall be deemed to have been reduced by the amount of such payment. 
  

	3.4	Purchase Price Allocation  

  
 The Sellers shall distribute the Purchase Price among the Sellers pro rata as set out in Part 1 of Schedule 1. 
  

 4 

	4	Conditions 

  

	4.1	Condition Precedent  

  
 The agreement to sell and purchase the Shares contained in Clause 2 is conditional upon (i) the Relevant Competition Authorities granting clearance of the
proposed acquisition of the Shares, or being deemed to have granted such a clearance. Further, the obligation for the Purchaser to purchase the Shares is conditional upon (ii) no breach of any of the Warranties having occurred, the effects of which
will have a material adverse effect on the Group as a whole and which cannot be remedied without unreasonable delay.  
  

	4.2	Responsibility for Satisfaction 

  

	 	4.2.1	The Purchaser shall be responsible for the preparation of notification to the competition authorities pursuant to Clause 4.1 (i) and for any costs and expenses incurred in
relation to such notification. The Purchaser undertakes to submit such notification as soon as reasonably possible and in accordance with the time limits as applicable within the relevant jurisdictions. The parties shall promptly provide each other
with any assistance, information and documentation reasonably required to prepare the notification. A party, which is notified by a competition authority that the condition in Clause 4.1 (i) may not be satisfied, or that satisfaction may be delayed,
shall immediately notify the other party. 

  

	 	4.2.2	The Purchaser shall use all reasonable endeavours to ensure the satisfaction of the condition set out in Clause 4.1 (i). 

  

	 	4.2.3	Without prejudice to Clauses 4.2.1 and 4.2.2, the Sellers and the Purchaser agree that all requests and enquiries from any government, governmental, supranational or trade
agency, court or other regulatory body shall be dealt with by the Sellers and the Purchaser in consultation with each other and the Sellers and the Purchaser shall promptly co-operate with and provide all necessary information and assistance
reasonably required by such government, agency, court or body upon being requested to do so by the other. 

  

	 	4.2.4	Without prejudice to Clauses 4.2.1 to 4.2.3, if the Purchaser is notified that the condition in Clause 4.1 (i) may not be satisfied, or that satisfaction may be delayed, the
Purchaser shall take all reasonable actions as required to ensure that the condition set out in Clause 4.1 (i) are fulfilled as soon as possible and in any event no later than the date set out in Clause 4.3, provided however that such actions would
not materially impact the value for the Purchaser of the transaction contemplated by this Agreement. 

  

	4.3	Non-satisfaction/Waiver 

  

	 	4.3.1	If the condition in Clause 4.1 (i) is not satisfied on or before 5 September 2005, or such other date as the parties may agree, the Sellers may terminate this Agreement
(other than the Surviving Clauses). 

  

	 	4.3.2	If the condition in Clause 4.1 (i) is not satisfied on or before 5 November 2005, the Purchaser may, provided that the Purchaser has taken all reasonable actions as required
to ensure the satisfaction of condition (i) set out in Clause 4.1, terminate this Agreement (other than the Surviving Clauses). 

  

 5 

	 	4.3.3	If the Agreement is terminated in accordance with Clause 4.3.1 or 4.3.2, no party shall have any claim against the other under this Agreement, save for any claim arising from
breach of any obligation contained in Clause 4.2. 

  

	5	Pre-Closing 

  

	5.1	The Sellers’ General Obligations Prior to Closing 

  
 Without prejudice to Clause 5.2, between the date of this Agreement and Closing the Sellers shall, and shall procure that the Group Companies shall,
consult with the Purchaser in relation to all material matters concerning the running of the Group. 
  

	5.2	The Sellers’ Obligations in Relation to the Conduct of Business 

  

Without prejudice to Clause 5.1, the Sellers shall between the date of this Agreement and Closing procure that each Group Company: 
  

	 	5.2.1	shall in all material respects carry on its business as a going concern in the ordinary course as carried on prior to the date of this Agreement; 

  

	 	5.2.2	without prejudice to the generality of Clause 5.2.1, shall not, without the prior written consent of the Purchaser, such consent not to be unreasonably withheld or delayed:

  

	 	(i)	enter into any agreement or incur any commitment involving any capital expenditure in excess of SEK 1,250,000 per item and SEK 5,000,000 in aggregate, in each case exclusive of
value added tax; 

  

	 	(ii)	enter into or amend any agreement or commitment which is not capable of being terminated without compensation at any time with twelve months’ notice or less or which is not in
the ordinary course of business or which involves or may involve total annual expenditure in excess of SEK 1,250,000, exclusive of value added tax; 

  

	 	(iii)	acquire or dispose of, or agree to acquire or dispose of any material asset involving consideration, expenditure or liabilities in excess of SEK 1,000,000, exclusive of value added
tax other than in the ordinary course of business; 

  

	 	(iv)	acquire or dispose of, or agree to acquire or dispose of, any share, shares or other interest in any company, partnership or other venture, other than as ordinary cash management;

  

	 	(v)	incur any additional borrowings or incur any other indebtedness, in each case in excess of SEK 1,000,000 exclusive of value added tax; 

  

	 	(vi)	allot, issue, redeem or repurchase any shares, options, warrants, conversion or offer rights to purchase shares of any Group Company or any securities convertible into or
exchangeable for such shares; 

  

	 	(vii)	declare, make or pay any dividend or other distribution to shareholders; 

  

	 	(viii)	make any change to the articles of association or other constitutional documents in the Company; or 

  

 6 

	 	(ix)	give notice of termination to any Key Employee or enter into employment agreement with any person on terms and conditions similar to the terms and conditions for a Key Employee.

  

	5.3	Minority Shareholders 

  
 Between the date of this Agreement and the Closing Date, the Sellers shall actively assist the Purchaser in soliciting the sale of the Minority Shares
from the Minority Shareholders to the Purchaser on the Closing Date. The Purchaser shall be obligated to purchase all Minority Shares offered for sale by the Minority Shareholders on terms and conditions which in substance correspond to those of the
Draft Minority Sellers’ Agreement. 
  

	6	Closing 

  

	6.1	Date and Place 

  
 Closing shall take place at the offices of Linklaters Advokatbyrå AB at Regeringsgatan 67, 103 98 Stockholm, Sweden, at 9.00 a.m. (CET), on the
fifth Business Day following fulfilment or waiver of the condition set out in Clause 4.1 (i), or at such other location, time or date as may be agreed between the Purchaser and the Sellers, provided however that, if the Purchaser claims that the
condition stipulated in Clause 4.1 (ii) is not satisfied, and the Sellers declare that the effects of the breach can be remedied without unreasonable delay, then, if the Purchaser so demands, the Closing shall be postponed until the effects of the
breach have been remedied. 
  

	6.2	Closing Events 

  

	 	6.2.1	On Closing the Sellers shall deliver or make available to the Purchaser: 

  

	 	(i)	evidence that the Sellers have given unconditional and irrevocable instructions to the relevant bank in order for the Shares to be transferred to the securities account of the
Purchaser and for the Purchaser to be registered as shareholder in the share register kept by VPC AB (the Swedish central securities depository and clearing house); and 

  

	 	(ii)	written resignations and confirmations (in such form as the Purchaser may reasonably require) by each retiring director, except directors and deputy directors appointed by employees
that none of them has any claim against any Group Company. 

  

	 	6.2.2	On Closing the Purchaser shall deliver or make available to the Sellers evidence of the due fulfilment of the condition set out in Clause 4.1 (i). 

 

	6.3	Payment on Closing 

  

	    	On Closing, the Purchaser shall pay the Purchase Price to the Sellers to the account specified by the Sellers in accordance with Clause 3.2. 

  

	7	Post-Closing Obligations 

  

	7.1	The Purchaser’s and Sellers’ Continuing Obligations 

  

	 	7.1.1	 The Purchaser shall as soon as possible after Closing hold general meetings and cause board meetings to be held to appoint new directors of the board and to
appoint company signatories in the Company and in the Subsidiaries. The 

  

 7 

	 	    	Purchaser shall cause to be prepared the minutes of said meetings as well as the necessary ancillary documentation, and shall procure that the documentation is submitted to the
relevant companies’ registry.  

  

	 	7.1.2	Pending the date when the Purchaser is entitled to vote for the Shares, the Sellers shall exercise all voting and other rights in relation to such Shares in accordance with
the Purchaser’s reasonable instructions. 

  

	 	7.1.3	The Purchaser shall, provided that the auditors do not recommend otherwise, discharge or procure the discharge of all directors of the board of the Company and the
Subsidiaries in office prior to Closing from their personal liability for the period up to and including the Closing Date at the next annual general meetings in the Company and the Subsidiaries. 

  

	7.2	Non-compete 

  

	 	7.2.1	Each Management Seller undertakes with the Purchaser that he or she will not during a period of two years from the Closing Date: 

  

	 	(i)	carry on, be engaged in or be economically interested in any Restricted Activity; 

  

	 	(ii)	canvass or solicit as a customer any person, firm or company who has within two years prior to Closing been a regular customer of any Group Company (to the extent related to a
Restricted Activity); or 

  

	 	(iii)	induce or seek to induce any Restricted Employee to become employed whether as employee, consultant or otherwise by any of the Sellers. The placing of an advertisement of a post
available to a member of the public generally and the recruitment of a person through an employment agency shall not constitute a breach of this Clause 7.2.1. 

  

	 	7.2.2	The restrictions in Clause 7.2.1 shall not operate to prohibit Bruno François Holding from being engaged in and owning 30.0% of NovAseptic Italia S.r.l.

  

	8	Warranties 

  

	8.1	The Sellers’ Warranties 

  

	 	8.1.1	The Sellers warrant to the Purchaser that the statements set out in Clause 8.3- 8.16 are in all material respects true and accurate as of the date of this Agreement and, save
as explicitly stated below, as of the Closing Date. The Sellers further warrant to comply with Clause 5 above. 

  

	 	8.1.2	Any Sellers’ Warranty qualified by the expression “so far as the Sellers are aware” or any similar expression shall, unless otherwise stated, be deemed to
refer to the knowledge of the persons whose names and addresses are set out in Schedule 6 who shall be deemed to have such knowledge as can reasonably be expected by a person in the respective position. 

  

	 	8.1.3	The Purchaser acknowledges that the Warranties do not release the Purchaser from the duty to carry out a customary due diligence review of the Group Companies.

  

 8 

	8.2	The Sellers’ Disclosures  

  

	 	8.2.1	The Sellers’ Warranties are subject to any matter which is contained in this Agreement or in the Disclosure Schedule. 

  

	 	8.2.2	The Data Room has been collated by the Sellers in good faith and the Sellers have not knowingly included any matter which is untrue or knowingly omitted any matter the
omission of which would make the contents of the Data Room materially misleading. 

  

	 	8.2.3	So far as the Sellers are aware, each document in the Data Room specified in the data room index is a true and complete copy of the original of such document. 

  

	 	8.2.4	The validation data provided by the Sellers on the request of the Purchaser have been collated by the Sellers in good faith and the Sellers have not knowingly included any
matter which is untrue or knowingly omitted any matter the omission of which would make the validation data materially misleading. 

  

	8.3	Corporate Information 

  

	 	8.3.1	Each Group Company is duly incorporated and validly existing under the laws of its respective jurisdiction. 

  

	 	8.3.2	The Sellers are the sole owner of the Shares and have the right to exercise all voting and other rights over the Shares. 

  

	 	8.3.3	The shares in the Company and Subsidiaries listed in Part 2 of Schedule 1 comprise the whole of the issued share capital of the Company and the Subsidiaries and each are
fully paid. All shares in the Subsidiaries are owned by the Company. 

  

	 	8.3.4	Except as set out in Schedule 7, no Group Company has issued or resolved to issue any financial instruments that entitles or may in the future entitle any person to
receive or acquire any share capital or any other security giving rise to a right over, or an interest in, the capital of any Group Company. 

  

	 	8.3.5	There are no Encumbrances over the shares in any Group Company. 

  

	 	8.3.6	The particulars contained in Part 1 of Schedule 1 are true and accurate. 

  

	 	8.3.7	The current articles of association of the Group Companies are those which are attached as Exhibit A and no decision has been adopted to amend any such document.

  

	 	8.3.8	The certificates of registration of the Group Companies attached as Exhibit A are true and accurate and up-to-date. 

  

	 	8.3.9	No Group Company is insolvent under the laws of the jurisdiction of its incorporation. 

  

	 	8.3.10	There are no proceedings in relation to any compromise or arrangement with creditors or any winding up, bankruptcy or other insolvency proceedings concerning any Group
Company. 

  

 9 

	8.4	Accounts 

  

	 	8.4.1	The Audited Accounts have been prepared in accordance with applicable law and with the accounting principles generally accepted at the Balance Sheet Date in Sweden.

  

	 	8.4.2	The Audited Accounts give in all material respects a true and fair view of the state of affairs (Sw. ställning) of the Company and the Group at the Balance Sheet
Date and of the profits or losses for the period concerned. 

  

	8.5	Financial Obligations 

  
 Except as set out in Schedule 8, and other than in the ordinary course of business, there is no outstanding guarantee, indemnity, suretyship (Sw.
borgen) or security given by any Group Company or for the benefit of any Group Company.  
  

	8.6	Assets 

  

	    	All material assets included in the Audited Accounts or acquired by any of the Group Companies since the Balance Sheet Date, other than any assets disposed of or realised in the
ordinary course of business: 

  

	 	(i)	are owned by the Group Companies; 

  

	 	(ii)	are in the possession or under the control of the relevant Group Company; and 

  

	 	(iii)	none of such assets is the subject of an Encumbrance. 

  

	8.7	Properties 

  

	 	8.7.1	So far as the Sellers are aware, there is no subsisting breach and no non-observance of any covenant, condition or agreement contained in the lease under which a Group
Company holds its interest in the Property, on the part of the relevant landlord or a Group Company which would materially adversely affect the business of the Group. 

  

	 	8.7.2	None of the Group Companies owns, or has owned, any Real Property.  

  

	8.8	Intellectual Property 

  

	 	8.8.1	All Business IP is (or, where appropriate in the case of pending applications, if and when granted, will be): 

  

	 	(i)	owned by a Group Company or lawfully used with the consent of the owner under a licence or otherwise used under the authority of the owner; 

  

	 	(ii)	valid and binding; 

  

	 	(iii)	so far as the Sellers are aware, not being infringed or attacked or opposed by any person; and 

  

	 	(iv)	no claims have been made and so far as the Sellers are aware no applications are pending, which if pursued or granted might be material to the truth and accuracy of any of the
above. 

  

	 	8.8.2	 So far as the Sellers are aware, the products (and the use thereof), the services and the business of the Group Companies at the date of this Agreement have
not infringed any rights or interests of third parties in Intellectual Property. No claims of 

  

 10 

	 	 
infringement of any such rights or interests have been made in any court or similar proceedings by any third party. 

  

	8.9	Agreements 

  

	 	8.9.1	All agreements material to the business of the Group to which any of the Group Companies is a party are listed in Schedule 9. 

  

	 	8.9.2	So far as the Sellers are aware, all material agreements referred to in Schedule 9 are valid and binding obligations of the parties thereto and the terms thereof have been
complied with in all material respects with by the relevant Group Company and by any other party to such agreements. 

  

	 	8.9.3	So far as the Sellers are aware at the date of this Agreement, no notice of termination or of intention to terminate, has been received in respect of any material agreements
referred to in Schedule 9. 

  

	 	8.9.4	No Group Company is a party to or subject to any material agreement, transaction, arrangement, understanding, obligation or liability which is not in the ordinary course of
business as carried on prior to the date of this Agreement. 

  

	 	8.9.5	There are no existing agreements or arrangements material to the business of the Group between, on the one hand, any Group Company and, on the other hand, the Sellers other
than on normal commercial terms in the ordinary course of business. 

  

	 	8.9.6	No Group Company is party to any agreement material to the business of the Group with any current or former director, officer, employee or agent of any such Group (whether
directly or indirectly), other than on normal commercial terms in the ordinary course of business. 

  

	 	8.9.7	So far as the Sellers are aware at the date of this Agreement, no counterparty will terminate its agreement as a consequence of the transaction contemplated by this
Agreement. 

  

	8.10	Employees and Employee Benefits  

  

	 	8.10.1	Since the Balance Sheet Date, no Group Company has made any material amendment to the terms and conditions of employment (including, without limitation, remuneration, pension
entitlements and other benefits) of any Key Employee. The terms and conditions of the employment agreements for all other employees, are in all material respects consistent with market practice. 

  

	 	8.10.2	As at the date of this Agreement, no Key Employee has given or received notice terminating his or her employment, and there have been no proposals to terminate the employment
of any Key Employee. 

  

	 	8.10.3	No liability which remains undischarged has been or may be incurred by any Group Company for breach of any agreement of employment with any employee or breach of an
employment right, whether based on statutory law or collective agreement. 

  

	 	8.10.4	The arrangements listed in Schedule 10, are the only arrangements under which the Group Companies are or may become liable to make payments for providing retirement,
death, disability or life assurance benefits (the “Pension Schemes”), except for arrangements to which any of the Group Companies contribute in compliance with any law. 

  

 11 

	 	8.10.5	There are no collective agreements affecting the employees of any Group Company. 

  

	8.11	Legal Compliance 

  

	 	8.11.1	All material licences, consents (including third party consents), authorisations, orders, warrants, confirmations, permissions, certificates, approvals, registrations and
authorities used in or necessary for the business of the Group as carried on have been obtained, are in force and are being, and have been, complied with in all material respects. 

  

	 	8.11.2	Each Group Company is in all material respects conducting the business of the Group in compliance with applicable laws and regulations in each country in which the business
of the Group is carried on. 

  

	 	8.11.3	No environmental permits are required for the business of the Group. 

  

	 	8.11.4	The Group Companies and their predecessors are, and have been, in compliance with all Environmental Laws, there has been no release or threatened release of any pollutant,
petroleum or any fraction thereof, contaminant or toxic or hazardous material (including toxic mold), substance or waste (each a “Hazardous Substance”) on, upon, into or from any site currently or heretofore owned, leased or
otherwise used by a Group Company or a predecessor, there have been no Hazardous Substances generated by a Group Company or a predecessor that have been disposed of or come to rest at any site that has been included in any published U.S. federal,
state or local superfund site list or any other similar list of hazardous or toxic waste sites published by any Governmental Authority in the United States, there are no underground storage tanks located on, no PCBs (polychlorinated biphenyls) or
PCB-containing Equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act stored on, any site owned or operated by a Group Company or a predecessor, except for the storage of hazardous waste in
compliance with Environmental Laws and the Sellers have made available to the Purchaser true, accurate and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications,
correspondence, engineering studies, and environmental studies or assessments, in each case as amended and in effect. “Environmental Laws” means any Legal Requirement relating to (a) releases or threatened releases of Hazardous
Substances, (b) pollution or protection of public health or the environment or worker safety or health or (c) the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances. 

  

	8.12	Litigation 

  

	 	8.12.1	No Group Company is involved whether as claimant or defendant or other party in any claim, legal action, proceeding, suit, litigation, prosecution, investigation, enquiry or
arbitration which is material to the business of the Group if adversely determined. 

  

	 	8.12.2	So far as the Sellers are aware, no such claim, legal action, proceeding, suit, litigation, prosecution, mediation, investigation, enquiry or arbitration of material
importance is pending or threatened by or against any Group Company. 

  

 12 

	8.13	Insurance 

  

	 	8.13.1	In respect of insurances: 

  

	 	(i)	all premiums have been duly paid to date; and 

  

	 	(ii)	all the policies are in full force and effect. 

  

	 	8.13.2	No insurance claim in excess of SEK 100,000 has been made during the two-year period prior to the date of this Agreement. 

  

	8.14	Tax  

  

	 	8.14.1	No Group Company is or will become liable for any Taxes pertaining to the period up to the Balance Sheet Date except as provided for in the Audited Accounts.

  

	 	8.14.2	Each Group Company has fully and timely paid all Taxes that have become due and has properly and timely made all such withholdings and deductions relating to Tax as are
required by law and has duly accounted for and delivered any such withholdings and deductions to the relevant authorities. 

  

	 	8.14.3	All information, notices, returns, declarations, registrations, claims for Reliefs and computations, which are or have been required to be made or given by each Group Company
for any Tax purpose have been made or given within the required periods and on a proper basis and are up-to-date and in all material respects correct. 

  

	 	8.14.4	No Group Company is subject to any tax audit nor is, as far as the Sellers are aware, any tax audit threatening. 

  

	8.15	Important Business Issues Since the Balance Sheet Date 

  

	    	Between the Balance Sheet Date and the date of this Agreement: 

  

	 	8.15.1	the business of the Group has been carried on as a going concern in the ordinary course; 

  

	 	8.15.2	no material capital commitments have been entered into or proposed by any Group Company. For these purposes a material capital commitment is one involving capital expenditure
in excess of SEK 1,250,000, exclusive of value added tax; 

  

	 	8.15.3	the business of the Group has not been materially and adversely affected by the loss of any important customer or source of supply. For these purposes, an important customer
or source of supply in relation to the Group means one which in either of the two financial periods immediately preceding the Balance Sheet Date accounted for 5 per cent. or more (in the case of a customer) of the turnover of the Group or (in the
case of a source of supply) of the goods, services or equipment supplied to the Group; 

  

	 	8.15.4	no Group Company has declared, made or paid any dividend or other distribution to its shareholders; 

  

	 	8.15.5	no Group Company has allotted, issued, redeemed or repurchased, or agreed to allot, issue, redeem or repurchase, any shares, options, warrants, conversion or offer rights to
purchase shares of any Group Company or any securities convertible into or exchangeable for such shares; and 

  

 13 

	 	8.15.6	otherwise than in the ordinary course of business, no Group Company has incurred any additional borrowings or incurred any other indebtedness, in each case in excess of SEK
1,000,000 exclusive of value added tax.  

  

	8.16	Authority and Capacity of the Sellers 

  

	 	8.16.1	The Sellers have the legal right and full power and authority to enter into and perform their duties and obligations under this Agreement and any other documents to be
executed by the Sellers pursuant to or in connection with this Agreement. 

  

	 	8.16.2	The execution and delivery of and the performance by the Sellers of their obligations under this Agreement and any other documents to be executed by the Sellers pursuant to
or in connection with this Agreement will not: 

  

	 	(i)	result in any breach of any provision of the articles of association of the Sellers; or 

  

	 	(ii)	result in a breach of any order, judgment or decree of any court, governmental agency or regulatory body. 

  

	8.17	The Purchaser’s Warranties 

  

	 	8.17.1	The Purchaser has the legal right and full power and authority to enter into and perform its duties and obligations under this Agreement and any other documents to be
executed by the Purchaser pursuant to or in connection with this Agreement. 

  

	 	8.17.2	The execution and delivery of and the performance by the Purchaser of its obligations under this Agreement and any other documents to be executed by the Purchaser pursuant to
or in connection with this Agreement will not: 

  

	 	(i)	result in any breach of any provision of the articles of association of the Purchaser; or 

  

	 	(ii)	result in a breach of any order, judgment or decree of any court, governmental agency or regulatory body. 

  

	9	Sellers’ Liability and Purchaser’s Remedies under this Agreement 

  

	9.1	Liability  

  

	 	9.1.1	In the event of any breach by the Sellers of this Agreement, the Sellers shall, subject to the provisions of this Agreement, indemnify the Purchaser in accordance with the
provisions of Clause 9.2 and 9.3. 

  

	 	9.1.2	The Sellers’ sole and exclusive liability in respect of the Shares or the Group Companies shall be under the Warranties, and the Sellers shall have no other liability in
respect thereof based on any other representation or warranty, express or implied, or any other agreement, contract, statute, including under the Swedish Sale of Goods Act (Sw. Köplagen, (1990:931)), or pursuant to legal theory or on any
other ground. 

  

	9.2	Remedies  

  

	 	9.2.1	 The Purchaser’s sole and exclusive remedy under this Agreement shall be to claim for a reduction of the Purchase Price pursuant to Clause 9.2.2 and the
Purchaser 

  

 14 

	 	 
shall not be entitled to any other remedies, including, without limitation, damages, termination or rescission of contract. Furthermore, a claim for a
reduction of the Purchase Price may only be made if the Sellers have failed to rectify the breach within 60 days of having received a notice pursuant to Clause 10.1.1. 

  

	 	9.2.2	A reduction of the Purchase Price for breach of any Sellers’ Warranty shall be for an amount corresponding to the Sellers’ pro rata share of the total number of
shares in the Company on a fully diluted basis (i.e. 90.12 per cent.) of the cost or liability incurred by the Group Companies, or to the diminution in value of the assets of the Group Companies constituting the breach, together with an amount
corresponding to the same pro rata share of reasonable costs, including without limitation reasonable legal fees, incurred by the Group Companies in connection with the breach. 

  

	 	9.2.3	For the avoidance of doubt, and without prejudice to the generality of Clause 9.2.1, the Sellers shall have no liability for any indirect loss suffered by the Purchaser,
including, without limitation, loss of synergies or loss of other similar profits, revenues or advantages that the Purchaser or its affiliated parties expected to make or obtain, or losses relating to liabilities or costs incurred or profits or
revenues lost, under the Purchaser’s existing contracts or under contracts that the Purchaser expects to, or will, enter into with third parties. 

  

	9.3	Proportionate and several liability etc. 

  

	    	The Sellers will only be liable to the Purchaser under this Agreement severally and in proportion to their respective shareholding (e.g. a Seller holding 10 per cent. of the Shares,
i.e. shares corresponding to 0.10*0.9012 of all the shares in the Company on a fully diluted basis, will only be liable for 0.10 of the reduction of the Purchase Price pursuant to Clause 9.2.2). A Seller shall never be liable for any liability
incurred due to another Seller’s fraud or gross negligence to the extent the liability relates to another Seller’s unencumbered title to the shares sold by such Seller or another Seller’s authority to enter into this Agreement.

  

	10	Limitation of Liability 

  

	10.1	Time Limitation for Claims 

  

	 	10.1.1	The Sellers shall not be liable under this Agreement in respect of any claim unless a notice of the claim is given by the Purchaser to the Sellers specifying full information
of the legal and factual basis of the claim and the evidence on which the Purchaser relies and, if possible, an estimate of the amount of losses which are, or are to be, the subject of the claim (including any losses which are contingent on the
occurrence of any future event): 

  

	 	(i)	in the case of any claim under Clauses 8.3, 8.11.3, 8.11.4, 8.14 and 8.16 within 36 months following Closing; and 

  

	 	(ii)	in the case of any other claim, within 18 months following Closing. 

  

	 	10.1.2	 If the Purchaser or a Group Company becomes aware, or should reasonably have become aware, of any matter or circumstance that may give rise to a claim
against the Sellers under this Agreement, the Purchaser shall within 30 days give a notice in writing to the Sellers setting out such information as is available to the Purchaser as is reasonably necessary to enable the Sellers to assess the merits
of the claim, 

  

 15 

	 	 
to act to preserve evidence and to make such provision as the Sellers may consider necessary. Failure to give notice within such period shall not affect the
rights of the Purchaser except to the extent that the Sellers are prejudiced by the failure.  

  

	 	10.1.3	The limitations in Clause 10.1.1 shall not apply to any claim under Clauses 8.3.2 and 8.16. 

  

	10.2	Minimum Claims 

  

	    	The Sellers shall not be liable under this Agreement in respect of: 

  

	 	10.2.1	any individual claim (or a series of claims arising from substantially identical facts or circumstances) where the liability agreed or determined in respect of any such claim
or series of claims does not exceed SEK 100,000;  

  

	 	10.2.2	any claim, except claims relating to Warranties given in Clause 8.14 Tax, unless the aggregate amount of all claims for which the Sellers would otherwise be liable under this
Agreement, except claims relating to Warranties given in Clause 8.14 Tax, exceeds SEK 12,000,000. Where the amount agreed or determined in respect of all claims referred to in this Clause 10.2.2 exceeds SEK 12,000,000, the liability of the Sellers
shall equal the entire amount and not merely the excess; and 

  

	 	10.2.3	any claim relating to Warranties given in Clause 8.14 Tax, unless the aggregate amount of all claims relating to Warranties given in Clause 8.14 Tax, for which the Sellers
would otherwise be liable, exceeds SEK 2,500,000. Where the amount agreed or determined in respect of all claims referred to in this Clause 10.2.3 exceeds SEK 2,500,000, the liability of the Sellers shall equal the entire amount and not merely the
excess. 

  

	    	The limitations stipulated in Clauses 10.2.2 and 10.2.3 above shall operate independently of each other and no claim relating to Warranties given in Clause 8.14 Tax may be taken
into account when determining whether the threshold stipulated in Clause 10.2.2 has been reached, and vice versa. 

  

	    	The limitations in this Clause 10.2 shall not apply to any claim under Clauses 8.3 and 8.16. 

  

	10.3	Maximum Liability 

  

	    	The aggregate liability of the Sellers in respect of all breaches of this Agreement shall not exceed 35 per cent. of the Purchase Price, except that such limitation shall not apply
to any claim under Clauses 8.3 and 8.16. Claims made under this Agreement shall however in aggregate never exceed the Purchase Price. 

  

	10.4	Provisions 

  

	    	The Sellers shall not be liable under this Agreement in respect of any claim if allowance, provisions or reserve is made in the Audited Accounts for the matter giving rise to the
claim. 

  

	10.5	Insurance 

  

	    	The Sellers shall not be liable under this Agreement in respect of any claim to the extent that the losses in respect of which such claim is made are covered by a policy of
insurance or would have been covered if all policies of insurance maintained by the Group Companies at Closing had been maintained also beyond Closing. 

  

 16 

	10.6	Tax Benefit 

  

	    	If any loss or cost for which the Sellers is liable under this Agreement is a tax-deductible item, the recoverable loss or cost shall be reduced by an amount equivalent to the loss
or cost multiplied by the corporate tax rate applicable in the relevant jurisdiction of the Purchaser or Group Company during the relevant fiscal year. 

  

	10.7	Purchaser’s Actual knowledge  

  

	    	The Sellers shall not be liable in respect of any claim to the extent that the relevant facts, matters or circumstances, giving rise to the claim were known by the Purchaser, which
for the purpose of this Clause 10.7 shall mean all information: 

  

	 	10.7.1	known to Joshua Silverstone, Eric Rudolph, Dennis Annarelli, Dana Hubbard, Suraj Baloda, or Cliff Abrecht at the time of the execution of this Agreement; and

  

	 	10.7.2	included in the reports from (a) Advokatfirman Vinge KB, (b) Ernst & Young, or (c) any of the persons listed in 10.7.1. 

  

	    	This Clause 10.7 shall not operate to bar the Purchaser from making any claims pursuant to Clause 8.14. 

  

	10.8	Mitigation of Losses 

  

	    	The Purchaser shall procure that all reasonable steps are taken and all reasonable assistance is given to avoid or mitigate any losses which in the absence of mitigation might give
rise to a liability in respect of any claim under this Agreement. 

  

	10.9	Contingent Liabilities 

  

	    	The Sellers shall not be liable under this Agreement in respect of any liability which is contingent unless and until such contingent liability becomes an actual and definitive
liability. 

  

	11	Third Party Claims 

  

	    	If a claim is made by a third party (including any claim by any Tax Authority) against the Company, for which, and to the extent that, the Purchaser intends to make a claim against
the Sellers for indemnification under this Agreement, then: 

  

	 	11.1.1	no admissions in relation to such third party claim shall be made by or on behalf of the Purchaser or any other member of the Purchaser’s Group and the claim shall not
be compromised, disposed of or settled without the written consent of the Sellers; 

  

	 	11.1.2	the Sellers shall be entitled, at their own expense and in their absolute discretion, by notice in writing to the Purchaser, to take such action as they shall deem necessary
to avoid, dispute, deny, defend, resist, appeal, compromise or contest such claim or liability in the name of and on behalf of the Purchaser or other member of the Purchaser’s Group concerned; 

  

	 	11.1.3	the Purchaser shall allow, and shall procure that the relevant Group Company allows, the Sellers and their advisers to investigate the matter or circumstance alleged to give
rise to a claim; and 

  

 17 

	 	11.1.4	the Purchaser shall, and the Purchaser shall procure that any other members of the Purchaser’s Group shall, give all such information and assistance as the Sellers may
reasonably request, including instructing such professional or legal advisers as the Sellers may nominate to act on behalf of the Purchaser or other member of the Purchaser’s Group concerned but in accordance with the Sellers’
instructions. 

  

	12	Confidentiality 

  

	12.1	Announcements 

  

	    	For a 12-month period after the date of this Agreement, the parties shall consult prior to making any announcement relating to the existence or the subject matter of this Agreement.
This shall not affect any announcement required by law or any regulatory body or the rules of any recognised stock exchange but the party (or any other company belonging to the same group as a party) with an obligation to make an announcement shall
consult with the other party insofar as is reasonably practicable before complying with such an obligation. 

  

	12.2	Disclosure 

  

	 	12.2.1	Subject to Clause 12.1, the parties undertake not to disclose or use any confidential information relating to the subject matter of this Agreement, any document referred to
herein, the negotiations relating to this Agreement, or any other Confidential Information unless (i) required to do so by law or by any applicable stock exchange regulations; (ii) to the professional advisers of any party on terms that such
professional advisers undertake to comply with the provisions of this Clause 12.2 in respect of such disclosure; (iii) the information is or becomes publicly available (other than by breach of this Agreement); or (iv) such disclosure has been
consented to by the other party in writing (such consent not to be unreasonably withheld). If a party is required to disclose or use information pursuant to (i) above, that party shall promptly notify the other party of such requirement with a view
to providing the other party with the opportunity to contest such disclosure or use or otherwise to agree to the timing and content of such disclosure or use. 

  

	 	12.2.2	The restrictions in Clause 12.2.1 shall not prevent the Purchaser from disclosing after Closing any Confidential Information, except such Confidential Information which
regards a Seller or a company affiliated with a Seller. 

  

	13	Other Provisions 

  

	13.1	Whole Agreement 

  

	    	This Agreement and, subject to the effects of Closing pursuant to Clause 12.2.2 if applicable, the Confidentiality Undertaking entered into, contain the whole agreement between the
parties relating to the subject matter of this Agreement at the date hereof to the exclusion of any terms implied by law which may be excluded by contract and supersede any previous written or oral agreement between the parties in relation to the
matters dealt with in this Agreement. 

  

 18 

	13.2	No Assignment 

  

	    	Except as otherwise expressly provided in this Agreement, neither party may without the prior written consent of the other party, assign, grant any security interest over or
otherwise transfer the benefit of the whole or any part of this Agreement. 

  

	13.3	Variation 

  

	    	No variation of this Agreement shall be effective unless in writing and signed by or on behalf of each of the parties. 

  

	13.4	Costs 

  

	    	The Sellers shall bear all costs incurred by them in connection with the preparation, negotiation and entry into of this Agreement. The Purchaser shall bear all such costs incurred
by it in connection with the preparation, negotiation and entry into of this Agreement. 

  

	13.5	Notices  

  

	 	13.5.1	Any notice in connection with this Agreement shall be: 

  

	 	(i)	in writing in English; 

  

	 	(ii)	delivered by hand, fax, registered post or by courier using an internationally recognised courier company. 

  

	 	13.5.2	A notice to the Sellers shall be sent to the following address, or such other person or address as the Sellers may notify to the Purchaser from time to time:

  

	 	    	Priveq Partners 

  

	 	    	Box 5295 

  

	 	    	S-102 46 Stockholm 

  

	 	    	Visit: Riddargatan 16 

  

	 	    	Fax: +46 (8) 20 35 66 

  

	 	    	Attention: The Managing Director 

  

	 	13.5.3	A notice to the Purchaser shall be sent to such party at the following address, or such other person or address as the Purchaser may notify to the Sellers from time to time:

  

	 	    	Millipore Corporation 

  

	 	    	290 Concord Road 

  

	 	    	Billerica, MA 01821 

  

	 	    	Fax: +1 978 715 13 82 

  

	 	    	Attention: General Counsel 

  

 19 

	 	    	With a copy to 

  

	 	    	Advokatfirman Vinge KB 

  

	 	    	P.O. Box 1703 

  

	 	    	111 87 Stockholm, Sweden 

  

	 	    	Fax: +46 (8) 614 31 90 

  

	 	    	Attention: Jan Lombach 

  

	 	13.5.4	A notice shall be effective upon receipt and shall be deemed to have been received: 

  

	 	(i)	at the time of delivery, if delivered by hand, registered post or courier; or 

  

	 	(ii)	at the time of transmission in legible form, if delivered by fax. 

  

	13.6	Invalidity 

  

	 	13.6.1	If any provision in this Agreement shall be held to be illegal, invalid or unenforceable, in whole or in part, such provision or part shall to that extent be deemed not to
form part of this Agreement but the legality, validity or enforceability of the remainder of this Agreement shall not be affected. 

  

	 	13.6.2	If any illegal, invalid or unenforceable provision would be legal, valid and enforceable if some part of it were deleted or modified, the provision shall apply with whatever
deletion or modification is necessary to give effect to the commercial intention of the parties. 

  

	13.7	Governing Law  

  

	    	This Agreement shall be solely governed by and construed in accordance with substantive Swedish law. 

  

	13.8	Arbitration  

  

	 	13.8.1	Any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach, termination or invalidity thereof, shall be finally settled by
arbitration in accordance with the Rules of the Arbitration Institute of the Stockholm Chamber of Commerce (the “SCC Institute”). The arbitral tribunal shall be composed of three arbitrators. 

  

	 	13.8.2	The language to be used in the arbitral proceedings shall be English. The place of arbitration shall be Stockholm. 

  

	 	13.8.3	If a request for arbitration comprises only some of the parties to this Agreement, all of the other parties to this Agreement shall be served the request for arbitration by
the SCC Institute before the SCC Institute refers the case to the tribunal. Should any party wish to join (Sw. kumulera) any other dispute, controversy or claim arising out of or in connection with this Agreement or intervene (Sw.
intervenera) in the proceeding, a request to do so shall be submitted in a request for arbitration within the time period determined by the SCC Institute. 

  

	 	13.8.4	 If a party submits a request for joinder or intervention after the time period determined by the SCC Institute, the arbitral tribunal shall decide whether to
allow such joinder or intervention. When deciding this, the arbitral tribunal shall take into 

  

 20 

	 	 
consideration the point in time at which the request for joinder or intervention was made, the prejudice that may be caused to the other parties if joinder
or intervention is allowed as well as other circumstances. 

  

	 	13.8.5	The parties to this Agreement agree that all arbitrators are to be appointed by the SCC Institute and that disputes, after joinder or intervention, shall be handled in a
single proceeding. 

  

	 	13.8.6	If joinder or intervention has occurred, the tribunal may decide that one or several disputes shall be handled in separate proceedings. Such a decision can only be made if
the parties have been granted the opportunity to state their opinion on this issue and after consultation with the arbitral tribunal. 

  

	 	13.8.7	Any arbitral tribunal established pursuant to this Agreement shall be bound by the award(s) of any previous arbitral tribunal(s) established pursuant to this Agreement.

  

	 	13.8.8	The parties undertake and agree that all arbitral proceedings conducted with reference to this Clause 13.8 will be kept strictly confidential. This confidentiality
undertaking shall cover all information disclosed in the course of such arbitral proceedings, as well as any decision or award that is made or declared during the proceedings. Information covered by this confidentiality undertaking may not, in any
form, be disclosed to a third party without the written consent of the other party. This notwithstanding, a party shall not be prevented from disclosing such information in order to safeguard in the best possible way his rights vis-à-vis the
other party in connection with the dispute, or if such a right or obligation exists pursuant to statute, regulation, law, a decision by an authority, a stock exchange contract or similar. 

  
 In witness whereof this Agreement has been duly executed. 
  

					
	MILLIPORE INTERNATIONAL HOLDING
COMPANY B.V.	 	 	 	SKANDIA INVESTMENT KB
			
	 /s/ Jeffrey Rudin

	 	 	 	 /s/ Magnus Hardmeier

	Jeffrey Rudin	 	 	 	through Magnus Hardmeier as per power of attorney

  

 21 

					
	QUINDA AB	 	 	 	SANIEL AB
			
	 /s/ Sten Johansson

	 	 	 	 /s/ Sten Johansson

	Sten Johansson	 	 	 	through Sten Johansson as per power of attorney
			
	BRUNO FRANÇOIS HOLDING	 	 	 	 
			
	 /s/ Sten Johansson

	 	 	 	 /s/ Sten Johansson

	through Sten Johansson as per power of attorney	 	 	 	Nils Årthun through Sten Johansson as per power of attorney
			
	 /s/ Johan Westman

	 	 	 	 
	Johan Westman	 	 	 	 

  
 We accept and agree to Clause 7.2
above. 
  

					
	 /s/ Sten Johansson

	 	 	 	 /s/ Sten Johansson

	Bruno François through Sten Johansson as per power of attorney	 	 	 	Nils Årthun through Sten Johansson as per power of attorney
			
	 /s/ Johan Westman

	 	 	 	 /s/ Sten Johansson

	Johan Westman	 	 	 	Sten Johansson

  

 22 

					
			
	 /s/ Sten Johansson

	 	 	 	 
	Håkan Samuelsson through Sten Johansson as per power of attorney	 	 	 	 

  

 23 

 Schedule 1 
 Particulars of the Sellers, etc. 

 Part 1 
  
 The Sellers 
  

					
	 Shareholder

	  	Capital & Votes

	 	No of Shares

	 Skandia Investment KB
	  	34.88%	 	2,400,000
	 Sten Johansson through Quinda AB
	  	16.75%	 	1,152,500
	 Håkan Samuelsson through Saniel AB
	  	16.75%	 	1,152,500
	 Nils Årthun
	  	15.35%	 	1,056,000
	 Bruno François through Bruno François Holding
	  	4.42%	 	304,000
	 Johan Westman
	  	1.96%	 	135,000*
	 	  	
	 	

	 Total
	  	appr. 90.12%**	 	6,200,000
	 	  	
	 	

	*	In addition, Johan Westman also held 500 option rights in the Company. The option rights have been exercised and the new shares are under registration (see below Schedule 7).

	**	On a fully diluted basis 

 Part 2 
  
 Particulars of the Subsidiaries 
  
 NovaSeptum AB (wholly owned by NovAseptic AB) 
 Org nr 556534-3521

 Rödjans väg 7 
 SE-449 34 Nödinge 
 SWEDEN 
  
 NovAseptic America Inc. (wholly owned by NovAseptic AB) 
 Reg No 22-3450556 
 96 Route 173 West, Suite # 3 
 NJ 08827, HAMPTON 
 U.S.A. 
  
 NovAsepticFrance S.A.S. (wholly
owned by NovAseptic AB) 
 Reg No 393-472-535 
 38, rue de la
République 
 F-69 150 Décines-Charpieu 
 FRANCE

  
 NovAseptic U.K. (wholly owned by NovAseptic AB) 
 Reg No 3792020 
 Tapton Park Innovation Centre 
 Brimington Road 
 Tapton 
 Chesterfield 
 Derbyshire 
 S41 0TZ 
 ENGLAND 
  
 NovAseptic Benelux B.V. (wholly owned by NovAseptic AB) 
 Reg No 08106454 
 Nordstraat 49 
 NL-4571 GC Axel 
 HOLLAND 
  
 NovAseptic Innovation A/S (wholly owned by NovAseptic AB) 
 Organisasjonsnummer 983170919 
 Strondlia 13 
 NO-4329 Sandnes 
 NORWAY 

 Schedule 3 
 Draft Minority Sellers’ Agreement 

 [Datum/Dated] 
  
 [PART/PARTY] 
  
 och 
 and 
  
 [PART/PARTY] 
  
 AKTIEÖVERLÅTELSEAVTAL 
  
 SHARE PURCHASE AGREEMENT 
  
 avseende aktier i 
 regarding shares in 
  
 NovAseptic AB (publ) 
  
 

 
  
 Linklaters Advokatbyrå 
 Regeringsgatan 67 
 Box 7833 
 SE-103 98 Stockholm 
  
 Telephone (46-8) 665 66 00 
 Facsimile (46-8) 667 68 83 

 [The English text is a translation] 
  
 Detta Aktieöverlåtelseavtal (“Avtalet”) har denna dag träffats mellan: 
  
 This Share Purchase Agreement (the
“Agreement”) is made on the date hereof between: 
  

	(3)	[•] (“Säljaren”), och 

  

	    	[•] (the “Vendor”); and 

  

	(4)	Millipore International Holding Company B.V., Paasheuvelweg 3, 1105 CE Amsterdam-Zuidoost, Nederländerna, (“Köparen”).

  

	    	Millipore International Holding Company B.V., Paasheuvelweg 3, 1105 CE Amsterdam-Zuidoost, the Netherlands, (the
“Purchaser”). 

  
 Bakgrund 
 Whereas: 
  

	(D)	Säljaren äger [•] aktier om nominellt 0,10 kronor (“Aktierna”) i NovAseptic AB (publ), ett publikt svenskt aktiebolag med org. nr.
556460-0830, (“Bolaget”).  

  

	    	The Vendor owns [•] shares of a nominal value of SEK 0.10 per share (the “Shares”) in NovAseptic AB (publ), a public limited liability company
incorporated under the laws of Sweden with Reg. No. 556460-0830, (the “Company”). 

  

	(E)	Den 6 juli 2005, träffades ett aktieöverlåtelseavtal mellan Köparen och huvudaktieägarna i Bolaget, genom vilket Köparen kommer att
förvärva över 90 procent av aktierna och rösterna i Bolaget (“Huvudaktieöverlåtelseavtalet”). 

  

	    	On 6 July 2005, the Purchaser and the main shareholders in the Company entered into a share purchase agreement, through which the Purchaser will acquire more than 90 per cent. of
the shares and votes in the Company (the “Main SPA”). 

  

	(F)	Säljaren har gått med på att sälja Aktierna och Köparen har gått med på att förvärva Aktierna för köpeskillingen
och på villkor som framgår av detta avtal. 

  

	    	The Vendor has agreed to sell the Shares and the Purchaser has agreed to purchase the Shares for the consideration and upon the terms set out in this Agreement.

  

	    	Följande har överenskommits: 

  

	    	It is agreed as follows: 

  

	1	Köp och försäljning av Aktierna 

	    	Sale and Purchase of the Shares 

  

	    	Säljaren överlåter härmed Aktierna till Köparen och Köparen köper härmed Aktierna från Säljaren fria från belastningar och
med samtliga tillhörande rättigheter. 

  

	    	The Vendor hereby sells the Shares to the Purchaser and the Purchaser hereby purchases the Shares from the Vendor free from any encumbrances whatsoever and together with all
rights attaching thereto. 

	2	Köpeskilling 

	    	Consideration 

  
 Köpeskillingen för Aktierna skall vara [•] kronor (“Köpeskillingen”) motsvarande ett pris per aktie av 104,65 kronor.

  
 The consideration for the Shares shall be SEK [•]
(the “Consideration”) which corresponds to a price per share of SEK 104.65. 
  

	3	Villkor 

 Condition 

 
 Parternas skyldighet att överlåta och tillträda Aktierna
enligt detta Avtal är beroende av att överlåtelse och tillträde av aktier enligt Huvudaktieöverlåtelseavtalet har skett (“Huvudtillträdet”). Om detta villkor inte är uppfyllt eller har
eftergivits av parterna senast den 30 november 2005, upphör detta Avtal att gälla och ingendera parten skall ha något anspråk mot den andra parten i anledning av detta Avtal. 
  
 The obligation to sell and purchase the Shares in accordance with this
Agreement is conditional upon closing of the Main SPA having occurred (the “ Main Closing”). If this condition is not satisfied or waived by the parties on or before 30 November 2005, this Agreement shall
lapse and no party shall have any claim against any other under it. 
  

	4	Tillträde 

 Closing

  

	4.1	Förutsatt att villkoret i punkt 3 har uppfyllts, skall tillträde av Aktierna i enlighet med punkt 1 (“Tillträde”) äga rum i direkt
anslutning till Huvudtillträdet eller så snart som möjligt därefter (“Tillträdesdagen”). Köparen skall underrätta Säljaren om tid och datum för Tillträde senast fem arbetsdagar
före Tillträdesdagen. Tillträde skall ske i Nödinge. 

  
 Subject to Clause 3, the completion of the sale and purchase of the Shares pursuant to Clause 1 (“Closing”) shall take place in immediate conjunction with the Main
Closing or as soon as possible thereafter (the “Closing Date”). The Purchaser shall notify the Vendor of the time and date of the Closing not later than five business days prior to the Closing Date.
Closing shall take place in Nödinge. 
  

	4.2	Säljaren skall på Tillträdesdagen tillse att dess kontoförande institut bekräftar att det mottagit oåterkalleliga instruktioner från
Säljaren att, samtidigt som (och villkorat av) Köparens överföring av Köpeskillingen enligt punkt 4.3 nedan, överföra alla Aktier till sådant VP-konto eller depositionskonto som Köparen skriftligen skall
ha angett senast tre arbetsdagar före Tillträdesdagen. 

  
 On the Closing Date, the Vendor shall ensure that its account operator confirms that it have received irrevocable instructions from the Vendor to transfer all of the Shares to such VP account or securities deposit
account as the Purchaser shall designate in writing not later than three business days prior to the Closing Date simultaneously with (and subject to) the transfer by the Purchaser of the Consideration in accordance with Clause 4.3 below.

	4.3	Köparen skall på Tillträdesdagen, efter bekräftelse från kontoförande institut i enlighet med punkt 4.2, erlägga Köpeskillingen till
Säljaren. Köpeskillingen skall betalas genom överföring av omedelbart tillgängligt kapital till [konto] i [bank] tillhörande [•] som erhållit fullmakt att för Säljarens räkning uppbära
Köpeskillingen. 

  
 On the Closing Date and
upon the account operator’s confirmation as referred to in Clause 4.2, the Purchaser shall pay to the Vendor the Consideration. The Consideration shall be paid by transfer of immediately available funds to [account] in [bank] belonging to
[•] who have been given a power of attorney to receive the Consideration on behalf of the Seller. 
  
 Detta Avtal har upprättats i två exemplar, varav parterna tagit var sitt. 
  
 This Agreement has been executed in two copies of which the parties have taken one each. 
  

	
	[Plats och datum/Place and date]
	
	[SÄLJARE/VENDOR]
	
	  

	
	[Plats och datum/Place and date]
	
	MILLIPORE INTERNATIONAL HOLDING COMPANY B.V.
	
	  

 Schedule 5 
 Relevant Competition Authorities 
  

			
	 Country

	    	 Authority

	Germany	    	Bundeskartellamt (Federal Cartel Office)

 Schedule 6 
 Sellers’ Knowledge 
  
 Bruno François, 1191 Chemin de Blazin, 30 000 Nimes, FRANCE 
  
 Magnus Hardmeier, Slåttergränd 37, 183 57 Täby, SWEDEN 
  
 Anna-Karin Jernberg, Hägerstensvägen 7, 421 67 Västra Frölunda, SWEDEN 
  
 Sten Johansson, Smedlyckan 18, 425 43 Hisings Kärra, SWEDEN 
  
 Håkan Samuelsson, Stigen 29, 439 92 Onsala, SWEDEN 
  
 Patrik Sundh, Spinspövägen 11, 423 41 Torslanda, SWEDEN

  
 Johan Westman, Lesikavägen 31, 427 40 Billdal, SWEDEN

  
 Nils Årthun, Strondlia 13, NO-4329 Sandnes, NORWAYForm of Option Agreement under 2002 Equity Incentive Plan

 Exhibit 10.1 
  
 COVALENT GROUP, INC. 
 2002 EQUITY INCENTIVE PLAN 
  
 INCENTIVE STOCK AWARD AGREEMENT 
  
 Covalent
Group, Inc. (the “Company”) hereby grants to                     (the “Optionee”) an option to purchase a total of
             shares of Common Stock of the Company (the “Option”), at the price and on the terms set forth herein, and in all respects subject to the terms, definitions and
provisions of the Covalent Group, Inc. 2002 Equity Incentive Plan (the “Plan”) applicable to incentive stock options, which terms and provisions are hereby incorporated by reference herein. Unless the context herein otherwise requires, the
terms defined in the Plan shall have the same meanings when used herein. 
  
 1. Nature of the Option. This Option is intended to be an incentive stock option described by Section 422 of the Internal Revenue Code of 1986, as amended. 
  
 2. Date of Grant; Term of Option. This Option is granted this
     day of             ,              (the “Date of Grant”) and it may not be
exercised later than the date that is five (5) years after the Date of Grant, subject to earlier termination, as provided in the Plan or Section 6 hereof. 
  
 3. Option Exercise Price. The cost to the Optionee to purchase, pursuant to this Award Agreement, one Share is $
            , which is the Fair Market Value on the Date of Grant. 
  
 4. Exercise of Option. This Option shall be exercisable during its term only in accordance with the terms and provisions of the Plan and this Award
Agreement as follows: 
  
 (a) Right to Exercise.

  
 (i) The Option shall become exercisable with
respect to              Shares if the Optionee remains continuously employed by the Company through the first (1st) anniversary of the Date of Grant. 
  
 (ii) The Option shall become exercisable with respect to              Shares if
the Optionee remains continuously employed by the Company through the second (2nd) anniversary of the Date of Grant.

  
 (iii) The Option shall become exercisable with respect
to              Shares if the Optionee remains continuously employed by the Company through the third (3rd) anniversary of the Date of Grant. 
  
 (b) Method of Exercise. The Optionee may exercise this Option by providing written notice stating the election to exercise this Option. Such
written notice must be signed by the Optionee and must be delivered in person or by certified mail to Donielle Massaro, Manager of Accounting of the Company or such other person as may be designated by the Company. The written notice must be
accompanied by payment of the option exercise price in 

 
the manner described in Section 4(c), by an executed exercise form provided by the administrator and by any other agreements required by the Board or its
Committee and/or the terms of the Plan, which other agreements may restrict the sale or other transfer of the Shares and may include certain additional representations and agreements as to the Optionee’s investment intent with respect to the
Shares. This Option will be deemed to be exercised only upon the receipt by the Company of such written notice, payment of the option exercise price, and duly executed copies of the exercise form and any other agreements required by the Board or its
Committee, the terms of the Plan and/or this Award Agreement. The Optionee will have no right to vote or receive dividends and will have no other rights as a stockholder with respect to such Shares notwithstanding the exercise of this Option, until
the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate(s) evidencing Shares that are being issued upon exercise of this Option. The
certificate(s) for the Shares will be registered in the name of the Optionee and will contain any legend as may be required under the Plan, this Award Agreement, and/or applicable law. 
  
 (c) Method of Payment. The method of payment of the option exercise price will be determined by the Board or its
Committee and may consist entirely of cash, certified check, or such other consideration or method of payment as may be authorized under the Plan. 
  
 (d) Partial Exercise. This Option may be exercised in whole or in part; provided, however, that any exercise may apply only with
respect to a whole number of Shares. 
  
 (e) Restrictions on
Exercise. This Option may not be exercised if the issuance of these Shares upon such exercise would constitute a violation of any applicable federal or state securities laws or other laws or regulations. In addition, as a further condition to
the exercise of this Option, the Company may require the Optionee to make any representation or warranty to the Company as may be required by or advisable under any applicable law or regulation. 
  
 5. Investment Representations. Unless the Shares have been registered
under the Securities Act of 1933, in connection with the acquisition of this Option, the Optionee represents and warrants to the Company as follows: 
  
 (a) The Optionee is acquiring this Option, and upon exercise of this Option, the Optionee will be acquiring the Shares for investment for his or
her own account, not as a nominee or agent, and not with a view to or for resale in connection with any distribution thereof. 
  
 (b) The Optionee has a preexisting business or personal relationship with the Company or one of its directors, officers or controlling persons and
by reason of his or her business or financial experience, has, and could be reasonably assumed to have, the capacity to protect his interests in connection with the acquisition of this Option and the Shares. 
  
 6. Termination of Relationship with the Company. 
  
 (a) Generally. If the Optionee’s employment by the Company is
terminated voluntarily for any reason other than death, Disability or termination for Cause, the Option (to 

 
the extent exercisable at the time of such termination) may be exercised at any time within three (3) months after the date of such termination. To the
extent that the Option is not exercisable at the time of such termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate. 
  
 (b) Disability. If the Optionee’s employment by the Company terminates due to Disability, the Option (to the
extent exercisable at the time of such termination) may be exercised by the Optionee or his legal guardian or representative at any time within twelve (12) months after such termination. To the extent that the Option is not exercisable on the date
of termination, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate. 
  
 (c) Death. If the Optionee’s employment by the Company terminates due to his death, the Option (to the extent exercisable at the time of such
death) will remain exercisable for twelve (12) months after the date of death by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance. To the extent that the Option is not exercisable on
the date of death, or to the extent the Option is not exercised within the time specified herein, the Option shall terminate. 
  
 (d) Termination for Cause. If the Optionee’s employment is terminated for Cause, the Option will then terminate immediately and automatically,
and the Optionee shall have no further rights therein. 
  
 Notwithstanding any
other provision of this Section 6, the Option shall not be exercisable after the expiration of the term set forth in Section 2 hereof. 
  
 7. Non-Transferability of Option. This Option may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed of in any manner
either voluntarily or involuntarily by operation of law, other than by will or by the laws of descent or distribution. During the Optionee’s lifetime, this Option is exercisable only by the Optionee (or by such Optionee’s legal guardian or
representative as provided in Section 6). Subject to the foregoing and the terms of the Plan, the terms of this Option will be binding upon the executors, administrators and heirs of the Optionee, meaning for purposes of this Award Agreement, both
testamentary heirs and heirs by intestacy. 
  
 8. No
Continuation of Employment or Engagement. Neither the Plan nor this Option shall confer upon any Optionee any right to continue in the service of the Company or any of its Subsidiaries or limit, in any respect, the right of the Company to
discharge the Optionee at any time, with or without cause and with or without notice. 
  
 9. Market Stand-Off. The Optionee agrees that, in connection with any public offering by the Company of its equity securities pursuant to a registration statement filed under the Securities Act, not to sell,
make any short sale of, loan, hypothecate, pledge, grant any option for the purchase of or otherwise dispose of any Shares without the prior written consent of the Company or its underwriters, for such period of time from the effective date of such
registration as may be requested by the Company or such underwriters. 

 10. Withholding. The Company reserves the right to withhold, in accordance with any applicable
laws, from any consideration payable or property transferable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this Option or the sale or other disposition of the Shares. If the
amount of any consideration payable to the Optionee is insufficient to pay such taxes or if no consideration is payable to the Optionee, upon the request of the Company, the Optionee (or such other person entitled to exercise this Option pursuant to
Section 6 hereof) will pay to the Company an amount sufficient for the Company to satisfy any federal, state or local tax withholding requirements applicable to the grant or exercise of this Option or the sale or other disposition of the Shares
issued upon the exercise of this Option. 
  
 11. The Plan.
The Optionee has received a copy of the Plan (a copy of which is attached hereto), has read the Plan and is familiar with its terms, and hereby accepts the Option subject to all of the terms and provisions of the Plan, as amended from time to
time. Pursuant to the Plan, the Board or its Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. The Optionee hereby agrees to accept as binding, conclusive and
final all decisions or interpretations of the Board or its Committee upon any questions arising under the Plan. 
  
 12. Governing Law. This Award Agreement will be construed in accordance with the laws of the State of Delaware, without regard to the application
of the principles of conflicts of laws. 
  
 13. Amendment.
Subject to the provisions of the Plan, this Award Agreement may only be amended by a writing signed by each of the parties hereto. 
  
 14. Conversion to Non-Qualified Option. Notwithstanding anything to the contrary set forth herein, the Option is being granted subject to the
condition that, if the Plan is not approved by the shareholders of the Company within 365 days of the date that the Plan was adopted by the Board, the Option shall automatically be converted into a non-qualified stock option. 
  
 15. Early Disposition of Stock. The Optionee hereby agrees that if the
Optionee disposes of any Shares received under the Option within one (1) year after such Shares were transferred to the Optionee, or within two (2) years after the date as of which the Option was granted, the Optionee will notify the Company in
writing within thirty days after the date of such disposition. 
  
 16. Entire Agreement. This Award Agreement, together with the Plan and the other exhibits attached thereto or hereto, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and
supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to the award of Options to Optionee by the Company. This Award Agreement may not be changed or modified, except by an agreement in writing
signed by each of the parties hereto. 
  
 IN WITNESS WHEREOF, this
Award Agreement has been executed by the parties on the      day of             ,
            . 

			
	COVALENT GROUP, INC.
		
	By:	 	  

	Name:	 	Kenneth M. Borow, M.D.
	Title:	 	Chief Executive Officer
	
	OPTIONEE
	  
  

	Signature
	  
  

	Address
	  
  

  
 THIS OPTION AND THE
SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED WITH A VIEW TO DISTRIBUTION OR
RESALE, AND MAY NOT BE SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL SATISFACTORY TO COVALENT GROUP, INC. THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.

 ACKNOWLEDGMENT 
  
 The Optionee acknowledges receipt of a copy of the Plan, a copy of which is attached hereto, and represents that he or she has read and is familiar with
the terms and provisions thereof and hereby accepts this Option subject to all of the terms and provisions of the Award Agreement and the Covalent Group, Inc. 2002 Equity Incentive Plan (the “Plan”). The Optionee hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Board or the Committee upon any questions arising under the Plan. 
  

			
	Date:                     	  	  

	 	  	Signature of Optionee
	 	  	  
  

	 	  	Name of Optionee
	 	  	  
  

	 	  	Address
	 	  	  
  

	 	  	City, State, Zip Code

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]